Francisco Sanchez-Vega

Dr. Michael Berger, Dr. David Solit, Dr. Marc Ladanyi, & the MSK-Impact team accept the @theaacr.bsky.social Team Science Award for developing & implementing a groundbreaking next-gen sequencing platform which has enabled the comprehensive molecular characterization of over 125,000 tumors. #AACR25

Fascinating insights from MSK gastrointestinal medical oncologist @karunamdphd.bsky.social on the role of #Ecoli in age-dependent cell cycle entry for early onset #colorectal cancer initiation. #AACR25 @theaacr.bsky.social

Beautiful weather in Barcelona to kick-off the AI in Drug Discovery and Biomedicine meeting. Thanks to @irbbarcelona.org for inviting me to present our work. #BarcelonaBiomed

Secondary Rectal Cancer After Radiotherapy for Prostate Cancer This case-control study compares the tumor molecular profiles, clinical characteristics, and oncologic outcomes between patients with primary rectal cancer and patients who develop secondary rectal ca...

Our new manuscript highlights distinct clinical and genomic features of patients who develop secondary rectal cancer years after being treated with radiotherapy for prostate cancer. #precisiononcology
jamanetwork.com/journals/jam...